Compile Data Set for Download or QSAR
Report error Found 152 with Last Name = 'young' and Initial = 'ja'
TargetPenicillin-binding protein 1A(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50012177(CHEMBL3265226)
Affinity DataIC50: 30nMAssay Description:Displacement of fluorescent Bocillin FL from N-terminal His tagged Pseudomonas aeruginosa PAO1 PBP1a (residues 36 to 822) expressed in Escherichia co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2015
Entry Details Article
PubMed
TargetPenicillin-binding protein 1A(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50012181(CHEMBL3265225)
Affinity DataIC50: 46nMAssay Description:Displacement of fluorescent Bocillin FL from N-terminal His tagged Pseudomonas aeruginosa PAO1 PBP1a (residues 36 to 822) expressed in Escherichia co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2015
Entry Details Article
PubMed
TargetPenicillin-binding protein 1A(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50012178(CHEMBL3265220)
Affinity DataIC50: 46nMAssay Description:Displacement of fluorescent Bocillin FL from N-terminal His tagged Pseudomonas aeruginosa PAO1 PBP1a (residues 36 to 822) expressed in Escherichia co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2015
Entry Details Article
PubMed
TargetPenicillin-binding protein 1A(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50012179(CHEMBL3265221)
Affinity DataIC50: 46nMAssay Description:Displacement of fluorescent Bocillin FL from N-terminal His tagged Pseudomonas aeruginosa PAO1 PBP1a (residues 36 to 822) expressed in Escherichia co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2015
Entry Details Article
PubMed
TargetPenicillin-binding protein 1A(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50012180(CHEMBL3265224)
Affinity DataIC50: 46nMAssay Description:Displacement of fluorescent Bocillin FL from N-terminal His tagged Pseudomonas aeruginosa PAO1 PBP1a (residues 36 to 822) expressed in Escherichia co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2015
Entry Details Article
PubMed
TargetPenicillin-binding protein 1A(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50012182(CHEMBL3265223)
Affinity DataIC50: 65nMAssay Description:Displacement of fluorescent Bocillin FL from N-terminal His tagged Pseudomonas aeruginosa PAO1 PBP1a (residues 36 to 822) expressed in Escherichia co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2015
Entry Details Article
PubMed
TargetGlucose-induced degradation protein 4 homolog(Human)
University of Toronto

Curated by ChEMBL
LigandPNGBDBM50589806(CHEMBL5177469)
Affinity DataKd:  81nMAssay Description:Binding affinity to recombinant GID4 (unknown origin) assessed as dissociation constant by surface plasmon resonance assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
PubMed
TargetPenicillin-binding protein 1A(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50012183(CHEMBL3265222)
Affinity DataIC50: 110nMAssay Description:Displacement of fluorescent Bocillin FL from N-terminal His tagged Pseudomonas aeruginosa PAO1 PBP1a (residues 36 to 822) expressed in Escherichia co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2015
Entry Details Article
PubMed
TargetGlucose-induced degradation protein 4 homolog(Human)
University of Toronto

Curated by ChEMBL
LigandPNGBDBM50621194(CHEMBL5393907)
Affinity DataKd:  300nMAssay Description:Binding affinity to recombinant GID4 (unknown origin) assessed as dissociation constant by surface plasmon resonance assayMore data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
PubMed
TargetGlucose-induced degradation protein 4 homolog(Human)
University of Toronto

Curated by ChEMBL
LigandPNGBDBM50621193(CHEMBL5411984)
Affinity DataKd:  500nMAssay Description:Binding affinity to recombinant GID4 (unknown origin) assessed as dissociation constant by surface plasmon resonance assayMore data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
PubMed
TargetGlucose-induced degradation protein 4 homolog(Human)
University of Toronto

Curated by ChEMBL
LigandPNGBDBM50589800(CHEMBL5197897)
Affinity DataKd:  2.30E+3nMAssay Description:Binding affinity to recombinant GID4 (unknown origin) assessed as dissociation constant by surface plasmon resonance assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/16/2024
Entry Details
PubMed
TargetGlucose-induced degradation protein 4 homolog(Human)
University of Toronto

Curated by ChEMBL
LigandPNGBDBM50621193(CHEMBL5411984)
Affinity DataIC50: 2.50E+3nMAssay Description:Displacement of C-terminal NanoLuc-tagged MPGLWKS peptide from N-terminal HaloTag-tagged GID4 (unknown origin) expressed in HEK293T cells incubated f...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
PubMed
TargetGlucose-induced degradation protein 4 homolog(Human)
University of Toronto

Curated by ChEMBL
LigandPNGBDBM50621191(CHEMBL5435433)
Affinity DataKd:  2.70E+3nMAssay Description:Binding affinity to recombinant GID4 (unknown origin) assessed as dissociation constant by surface plasmon resonance assayMore data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
PubMed
TargetPenicillin-binding protein 1A(Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 /...)
Pfizer

Curated by ChEMBL
LigandPNGBDBM50240480(CHEMBL158 | (2S,3S)-3-({(2Z)-2-(2-ammonio-1,3-thia...)
Affinity DataIC50: 3.34E+3nMAssay Description:Displacement of fluorescent Bocillin FL from N-terminal His tagged Pseudomonas aeruginosa PAO1 PBP1a (residues 36 to 822) expressed in Escherichia co...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/9/2015
Entry Details Article
PubMed
TargetGlucose-induced degradation protein 4 homolog(Human)
University of Toronto

Curated by ChEMBL
LigandPNGBDBM50621190(CHEMBL5405098)
Affinity DataKd:  3.40E+3nMAssay Description:Binding affinity to recombinant GID4 (unknown origin) assessed as dissociation constant by surface plasmon resonance assayMore data for this Ligand-Target Pair
Ligand InfoPDBSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetPotassium voltage-gated channel subfamily H member 2(Human)
China Innovation Center of Roche

Curated by ChEMBL
LigandPNGBDBM50617145(CHEMBL5394132)
Affinity DataIC50: 7.80E+3nMAssay Description:Inhibition of hERG stably expressed in CHO cells by whole-cell voltage-clamp assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetGlucose-induced degradation protein 4 homolog(Human)
University of Toronto

Curated by ChEMBL
LigandPNGBDBM50621189(CHEMBL5414824)
Affinity DataKd:  9.00E+3nMAssay Description:Binding affinity to recombinant GID4 (unknown origin) assessed as dissociation constant by surface plasmon resonance assayMore data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
China Innovation Center of Roche

Curated by ChEMBL
LigandPNGBDBM50617149(CHEMBL5416588)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of hERG stably expressed in CHO cells by whole-cell voltage-clamp assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
China Innovation Center of Roche

Curated by ChEMBL
LigandPNGBDBM50617142(CHEMBL5440696)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of hERG stably expressed in CHO cells by whole-cell voltage-clamp assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetGlucose-induced degradation protein 4 homolog(Human)
University of Toronto

Curated by ChEMBL
LigandPNGBDBM50621188(CHEMBL5426366)
Affinity DataKd:  1.50E+4nMAssay Description:Binding affinity to recombinant GID4 (unknown origin) assessed as dissociation constant by surface plasmon resonance assayMore data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
China Innovation Center of Roche

Curated by ChEMBL
LigandPNGBDBM50617150(CHEMBL5419005)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of hERG stably expressed in CHO cells by whole-cell voltage-clamp assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
China Innovation Center of Roche

Curated by ChEMBL
LigandPNGBDBM50617148(CHEMBL5408647)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of hERG stably expressed in CHO cells by whole-cell voltage-clamp assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
China Innovation Center of Roche

Curated by ChEMBL
LigandPNGBDBM50617143(CHEMBL5438938)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of hERG stably expressed in CHO cells by whole-cell voltage-clamp assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
China Innovation Center of Roche

Curated by ChEMBL
LigandPNGBDBM50617141(CHEMBL5436316)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of hERG stably expressed in CHO cells by whole-cell voltage-clamp assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
China Innovation Center of Roche

Curated by ChEMBL
LigandPNGBDBM50617146(CHEMBL5431096)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of hERG stably expressed in CHO cells by whole-cell voltage-clamp assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
China Innovation Center of Roche

Curated by ChEMBL
LigandPNGBDBM50617147(CHEMBL5437421)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of hERG stably expressed in CHO cells by whole-cell voltage-clamp assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetPotassium voltage-gated channel subfamily H member 2(Human)
China Innovation Center of Roche

Curated by ChEMBL
LigandPNGBDBM50617144(CHEMBL5403174)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of hERG stably expressed in CHO cells by whole-cell voltage-clamp assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2024
Entry Details
PubMed
TargetGlucose-induced degradation protein 4 homolog(Human)
University of Toronto

Curated by ChEMBL
LigandPNGBDBM50621192(CHEMBL5411414)
Affinity DataKd:  2.40E+4nMAssay Description:Binding affinity to recombinant GID4 (unknown origin) assessed as dissociation constant by surface plasmon resonance assayMore data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
PubMed
TargetBaculoviral IAP repeat-containing protein 7(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM391852(US10300074, Compd 47)
Affinity DataKi: <2.50E+4nMAssay Description:5000 PPC-1 cells were plated and grown overnight. Compounds were plated and 4 hrs later, TRAIL was added to half of the plate while RPMI was added to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2020
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase XIAP [241-356](Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM391852(US10300074, Compd 47)
Affinity DataKi: <2.50E+4nMAssay Description:5000 PPC-1 cells were plated and grown overnight. Compounds were plated and 4 hrs later, TRAIL was added to half of the plate while RPMI was added to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2020
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase XIAP [241-356](Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM391850(US10300074, Compd 45)
Affinity DataKi: <2.50E+4nMAssay Description:5000 PPC-1 cells were plated and grown overnight. Compounds were plated and 4 hrs later, TRAIL was added to half of the plate while RPMI was added to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2020
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase XIAP [1-168]/[124-242](Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM391850(US10300074, Compd 45)
Affinity DataKi: <2.50E+4nMAssay Description:5000 PPC-1 cells were plated and grown overnight. Compounds were plated and 4 hrs later, TRAIL was added to half of the plate while RPMI was added to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2020
Entry Details
US Patent

TargetBaculoviral IAP repeat-containing protein 7(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM391849(US10300074, Compd 44)
Affinity DataKi: <2.50E+4nMAssay Description:5000 PPC-1 cells were plated and grown overnight. Compounds were plated and 4 hrs later, TRAIL was added to half of the plate while RPMI was added to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2020
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase XIAP [241-356](Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM391849(US10300074, Compd 44)
Affinity DataKi: <2.50E+4nMAssay Description:5000 PPC-1 cells were plated and grown overnight. Compounds were plated and 4 hrs later, TRAIL was added to half of the plate while RPMI was added to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2020
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase XIAP [1-168]/[124-242](Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM391852(US10300074, Compd 47)
Affinity DataKi: <2.50E+4nMAssay Description:5000 PPC-1 cells were plated and grown overnight. Compounds were plated and 4 hrs later, TRAIL was added to half of the plate while RPMI was added to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2020
Entry Details
US Patent

TargetBaculoviral IAP repeat-containing protein 7(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM391851(US10300074, Compd 46 | US11111270, Compound 46)
Affinity DataKi: <2.50E+4nMAssay Description:5000 PPC-1 cells were plated and grown overnight. Compounds were plated and 4 hrs later, TRAIL was added to half of the plate while RPMI was added to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2020
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase XIAP [241-356](Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM391851(US10300074, Compd 46 | US11111270, Compound 46)
Affinity DataKi: <2.50E+4nMAssay Description:5000 PPC-1 cells were plated and grown overnight. Compounds were plated and 4 hrs later, TRAIL was added to half of the plate while RPMI was added to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2020
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase XIAP [1-168]/[124-242](Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM391805(US10300074, Product 17b)
Affinity DataKi: <2.50E+4nMAssay Description:5000 PPC-1 cells were plated and grown overnight. Compounds were plated and 4 hrs later, TRAIL was added to half of the plate while RPMI was added to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2020
Entry Details
US Patent

TargetBaculoviral IAP repeat-containing protein 7(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM391804(US10300074, Product 17a | US11111270, Compound 27)
Affinity DataKi: <2.50E+4nMAssay Description:5000 PPC-1 cells were plated and grown overnight. Compounds were plated and 4 hrs later, TRAIL was added to half of the plate while RPMI was added to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2020
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase XIAP [241-356](Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM391804(US10300074, Product 17a | US11111270, Compound 27)
Affinity DataKi: <2.50E+4nMAssay Description:5000 PPC-1 cells were plated and grown overnight. Compounds were plated and 4 hrs later, TRAIL was added to half of the plate while RPMI was added to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2020
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase XIAP [241-356](Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM391806(US10300074, Product 17c | US11111270, Compound 35)
Affinity DataKi: <2.50E+4nMAssay Description:5000 PPC-1 cells were plated and grown overnight. Compounds were plated and 4 hrs later, TRAIL was added to half of the plate while RPMI was added to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2020
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase XIAP [1-168]/[124-242](Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM391806(US10300074, Product 17c | US11111270, Compound 35)
Affinity DataKi: <2.50E+4nMAssay Description:5000 PPC-1 cells were plated and grown overnight. Compounds were plated and 4 hrs later, TRAIL was added to half of the plate while RPMI was added to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2020
Entry Details
US Patent

TargetBaculoviral IAP repeat-containing protein 7(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM391805(US10300074, Product 17b)
Affinity DataKi: <2.50E+4nMAssay Description:5000 PPC-1 cells were plated and grown overnight. Compounds were plated and 4 hrs later, TRAIL was added to half of the plate while RPMI was added to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2020
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase XIAP [241-356](Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM391805(US10300074, Product 17b)
Affinity DataKi: <2.50E+4nMAssay Description:5000 PPC-1 cells were plated and grown overnight. Compounds were plated and 4 hrs later, TRAIL was added to half of the plate while RPMI was added to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2020
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase XIAP [241-356](Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM391813(US10300074, Compd 9 | US11111270, Compound 9)
Affinity DataKi: <2.50E+4nMAssay Description:5000 PPC-1 cells were plated and grown overnight. Compounds were plated and 4 hrs later, TRAIL was added to half of the plate while RPMI was added to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2020
Entry Details
US Patent

TargetBaculoviral IAP repeat-containing protein 7(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM391806(US10300074, Product 17c | US11111270, Compound 35)
Affinity DataKi: <2.50E+4nMAssay Description:5000 PPC-1 cells were plated and grown overnight. Compounds were plated and 4 hrs later, TRAIL was added to half of the plate while RPMI was added to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2020
Entry Details
US Patent

TargetBaculoviral IAP repeat-containing protein 7(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM391819(US10300074, Compd 14 | US11111270, Compound 14)
Affinity DataKi: <2.50E+4nMAssay Description:5000 PPC-1 cells were plated and grown overnight. Compounds were plated and 4 hrs later, TRAIL was added to half of the plate while RPMI was added to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2020
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase XIAP [241-356](Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM391819(US10300074, Compd 14 | US11111270, Compound 14)
Affinity DataKi: <2.50E+4nMAssay Description:5000 PPC-1 cells were plated and grown overnight. Compounds were plated and 4 hrs later, TRAIL was added to half of the plate while RPMI was added to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2020
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase XIAP [241-356](Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM391817(US10300074, Compd 13)
Affinity DataKi: <2.50E+4nMAssay Description:5000 PPC-1 cells were plated and grown overnight. Compounds were plated and 4 hrs later, TRAIL was added to half of the plate while RPMI was added to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2020
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase XIAP [241-356](Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM391821(US10300074, Compd 16)
Affinity DataKi: <2.50E+4nMAssay Description:5000 PPC-1 cells were plated and grown overnight. Compounds were plated and 4 hrs later, TRAIL was added to half of the plate while RPMI was added to...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2020
Entry Details
US Patent

Displayed 1 to 50 (of 152 total ) | Next | Last >>
Jump to: